Sign in

CIK 0002020932 · Non-accelerated filer<br>Emerging growth company

AgomAb Therapeutics NV

Sign in to watch
Ticker
AGMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Belgium
Entity type
other
Phone
32 3 302 35 30
Business address
POSTHOFLEI 1/6, ANTWERPEN, Belgium, 2600
  1. 6-K Event Report of Foreign Issuer
  2. 6-K Event Report of Foreign Issuer
  3. 6-K Event Report of Foreign Issuer
  4. 6-K Event Report of Foreign Issuer
  5. 6-K Event Report of Foreign Issuer
  6. 6-K Event Report of Foreign Issuer
  7. 6-K Event Report of Foreign Issuer
  8. 6-K Event Report of Foreign Issuer
  9. 6-K Event Report of Foreign Issuer
  10. 20-F Report Annual and Transition Report of Foreign Private Issuers
  11. 6-K Event Report of Foreign Issuer
  12. 6-K Event Report of Foreign Issuer
  13. F-1/A Offering Registration Statement for Certain Foreign Private Issuers
  14. F-1 Offering Registration Statement for Certain Foreign Private Issuers

Page 1 of 1 · 14 filings